Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques

Sander Herfst, Eefje Schrauwen, Miranda de Graaf, Geert Amerongen, BG van den Hoogen, Rik de Swart, Ab Osterhaus, Ron Fouchier

Research output: Contribution to journalArticleAcademicpeer-review

38 Citations (Scopus)


Human metapneumovirus (HMPV) is an important cause of acute respiratory tract disease for which the development of vaccine candidates is warranted. We have previously described the generation of an iscom matrix-adjuvanted HMPV fusion protein subunit vaccine (Fsol) and a live-attenuated vaccine (HMPVM11). Here, we evaluate the immunogenicity and efficacy of these vaccines in cynomolgus macaques. Immunization with Fsol induced HMPV F-specific antibody responses, virus neutralizing antibody titers, and cellular immune responses, but the induced humoral immune response waned rapidly over time. HMPVM11 was strongly attenuated and displayed limited immunogenicity, although immunization with this virus rimed for a good secondary HMPV-specific lymphoproliferative response after challenge infection. The duration of virus shedding in HMPVM11-immunized animals was reduced compared to sham-immunized animals. Both vaccines induced HMPV-specific immune responses, but the rapid waning of immunity is a challenging obstacle for vaccine development. (C) 2008 Elsevier Ltd. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)4224-4230
Number of pages7
Issue number33
Publication statusPublished - 2008

Cite this